A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy
Completed
Abbott
Phase 2
The objective of this study is to evaluate the effects of 10 mg and 25 mg doses of
asoprisnil, compared to placebo, taken daily for 12 weeks, on uterine blood flow and the
morphology of the endometrium and uterine fibroids.
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
Completed
Abbott
Phase 3
The objective of this study is to determine the safety and efficacy effects of two doses of
asoprisnil (10 mg and 25 mg) compared with placebo when administered daily for 6 months to
premenopausal subjects with symptomatic uterine leiomyomata.
Treatment of Uterine Fibroids With Asoprisnil(J867)
Completed
Abbott
Phase 3
The objective of this study is to determine the safety and effectiveness of asoprisnil in
symptomatic women with abnormal uterine bleeding associated with uterine fibroids.
A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
Completed
Abbott
Phase 2
The objective of this study is to determine the safety and effectiveness of 3 asoprisnil
doses when administered to postmenopausal women with Premarin® 0.625 mg.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
